Experience of status epilepticus in the Neurology department of a tertiary-level hospital in Mexico

Authors

  • Julián Alberto Hernández-Domínguez <p>Instituto Mexicano del Seguro Social, Hospital de Especialidades, Centro M&eacute;dico Nacional Siglo XXI, Servicio de Neurolog&iacute;a.&nbsp;Ciudad de M&eacute;xico</p>
  • Gretel Cano-Salazar <p>Instituto Mexicano del Seguro Social,&nbsp;Hospital de Especialidades, Centro M&eacute;dico Nacional Siglo XXI,&nbsp;Servicio de Neurolog&iacute;a.&nbsp;Ciudad de M&eacute;xico</p>
  • Alejandra Calderón-Vallejo <p>Instituto Mexicano del Seguro Social,&nbsp;Hospital de Especialidades, Centro M&eacute;dico Nacional Siglo XXI,&nbsp;Servicio de Neurolog&iacute;a.&nbsp;Ciudad de M&eacute;xico</p>
  • Carlos Fredy Cuevas-García <p>Instituto Mexicano del Seguro Social,&nbsp;Hospital de Especialidades, Centro M&eacute;dico Nacional Siglo XXI,&nbsp;Servicio de Neurolog&iacute;a.&nbsp;Ciudad de M&eacute;xico</p>

Keywords:

Status Epilepticus, Seizures, Epilepsy, Etiology

Abstract

Background: The status epilepticus is a neurological emergency that continues to be little identified early in emergency rooms and hospitalized patients, with significant morbidity and mortality. The aim of this paper was to establish the etiology and evolution of the status epilepticus in hospitalized patients in a tertiary-level hospital.

Methodology: Descriptive, cross-analytical study of adult patients hospitalized with the diagnosis of epileptic status at a tertiary-level hospital, between August 2010 and February 2016.

Results: 19 patients, mean age 35 years ± 19. With 15 years of convulsive epileptic status, 13 subjects with generalized seizures, 4 with alert alterations and 2 with focal seizures. In 4 cases, structural damage was detected, 4 due to non-specific inflammation, 2 due to neuroinfection, 2 with anoxoischemic encephalopathy and 3 cases without evident etiology; of the 17 survivors, 10 with Rankin Scale modified from 4-5 points.

Conclusions: The status epilepticus is a common diagnosis in third level centers, with significant morbi mortality. After a complete study protocol, the etiological diagnosis is reached in most cases.

Downloads

Download data is not yet available.

References

Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40:120-122.

 

Walker MC. Diagnosis and treatment of nononvulsive status epilepticus. CNS Drugs. 2001;15:931-9.

 

Kaplan PW. EEG criteria for nonconvulsive status epilepticus. Epilepsia. 2007;48(Suppl 8):39-41.

 

Hauser WA. Status epilepticus: epidemiologic considerations. Neurology. 1990;40(5 Suppl 2):9-13.

 

Lowenstein D, Betjemann J. Status epilepticus in adults. Lancet Neurol. 2015;14:615-24.

 

Hantus S. Epilepsy emergencies. Continuum. 2016;22(1):173-190.

 

Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology. 1993;43:1042-4.

 

Gaspard N. Autoimmune Epilepsy. Continuum. 2016; 22(1): 227-245.

 

Spanaki M, Varelas P, Mirski MA. Status epilepticus: An update. Curr Neurol Neurosci Rep. 2013;13(7):357.

 

DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39(9):833-40.

 

Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology. 1992;42: 100-04.

 

Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia. 2001;42(9):1212-1218.

 

Lawrence JH, Gaspard N. Status Epilepticus. Continuum (Minneap Minn) 2013;19(3):767-794.

 

Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40(Suppl 1):S3-8.

 

Alldredge BK, Gelb AM, Isaacs SM. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631-7.

 

Rossett A, Lowenstein D. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922-30.

 

Chen J, Wasterlain C. Status epilepticus: Pathophysiology and management in adults. Lancet Neurol. 2006;5:246-56.

 

Hocker S, Tatum W, LaRoche S, Freeman WD. Refractory and Super-Refractory Status Epilepticus: an Update. Curr Neurol Neurosci Rep. 2014;14(6):452.

 

Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70(1):72-7.

 

Kilbride RD, Reynolds AS, Szaflarski JP, Hirsch LJ. Clinical outcomes following prolonged refractory status epilepticus (PRSE). Neurocrit Care. 2013;18(3):374-85.

 

Kumar M, Chakravarthi S, Modi M. Status epilepticus severity score (STESS): A useful tool to predictoutcome of status epilepticus. Clinical Neurology and Neurosurgery. 2015;139(20):96-99.

 

Pacha M, Orellana L, Silva E. Role of EMSE and STESS scores in the outcome evaluation of status epilepticus. Epilepsy & Behavior. 2016;64:140-142

Downloads

Published

2018-07-17

Issue

Vol. 55 No. Suplemento 4 (2017)

Section

Original Articles

License

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.